{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:27:42Z","timestamp":1789162062827,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejso.2024.108258","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:04:26Z","timestamp":1709856266000},"page":"108258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic value of lymph node ratio in patients with non-metastatic cervical cancer treated with radical hysterectomy: A population-based study"],"prefix":"10.1016","volume":"50","author":[{"given":"Yingyue","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2024.108258_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.ejso.2024.108258_bib2","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.ejso.2024.108258_bib3","first-page":"57","article-title":"Comparison of postoperative adjuvant chemotherapy and concurrent chemoradiotherapy for FIGO2018 stage IIIC1 cervical cancer: a retrospective study","author":"Kagabu","year":"2021","journal-title":"Medicina-Lithuania"},{"key":"10.1016\/j.ejso.2024.108258_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10147-007-0661-2","article-title":"Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer","volume":"12","author":"Sakuragi","year":"2007","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ygyno.2004.01.038","article-title":"Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer","volume":"93","author":"Havrilesky","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib6","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.3802\/jgo.2018.29.e11","article-title":"Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB-IIB cervical cancer","volume":"29","author":"Matsuo","year":"2018","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/IGC.0000000000000177","article-title":"Pretreatment retroperitoneal para-aortic lymph node staging in advanced cervical cancer: a review","volume":"24","author":"Smits","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2024.108258_bib8","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/bjc.2013.78","article-title":"Utility of risk-weighted surgical-pathological factors in early-stage cervical cancer","volume":"108","author":"Matsuo","year":"2013","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.ejso.2024.108258_bib9","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1245\/s10434-013-3067-6","article-title":"The role of lymphadenectomy in cervical cancer patients: the significance of the number and the status of lymph nodes removed in 526 cases treated in a single institution","volume":"20","author":"Ditto","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1525-1438.2007.01176.x","article-title":"The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients","volume":"18","author":"Kotowicz","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2024.108258_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186165","article-title":"The value of squamous cell carcinoma antigen (SCCa) to determine the lymph nodal metastasis in cervical cancer: a meta-analysis and literature review","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejso.2024.108258_bib12","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/tbj.13988","article-title":"Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy","volume":"26","author":"De la Cruz-Ku","year":"2020","journal-title":"Breast J"},{"key":"10.1016\/j.ejso.2024.108258_bib13","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1097\/SLA.0000000000005450","article-title":"Lymph node ratio improves prediction of overall survival in esophageal cancer patients receiving neoadjuvant chemoradiotherapy: a national cancer database analysis","volume":"277","author":"Zhang","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2024.108258_bib14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41598-017-00619-5","article-title":"Prognostic and predictive effects of positive lymph node number or ratio in NSCLC","volume":"7","author":"Ding","year":"2017","journal-title":"Sci Rep-UK"},{"key":"10.1016\/j.ejso.2024.108258_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jjco\/hyz120","article-title":"Prognostic value of lymph node ratio in non-small-cell lung cancer: a meta-analysis","volume":"50","author":"Zhou","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2014.11.010","article-title":"Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer","volume":"136","author":"Fleming","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3349\/ymj.2021.62.3.231","article-title":"Lymph node ratio is a strong prognostic factor in patients with early-stage cervical cancer undergoing minimally invasive radical hysterectomy","volume":"62","author":"Kim","year":"2021","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.ejso.2024.108258_bib18","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.2147\/CMAR.S253522","article-title":"Risk stratification based on metastatic pelvic lymph node status in stage IIIC1p cervical cancer","volume":"12","author":"Li","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ejso.2024.108258_bib19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3802\/jgo.2020.31.e1","article-title":"The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy","volume":"31","author":"Aslan","year":"2020","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011711","article-title":"Prognostic significance of lymph node ratio in node-positive cervical cancer patients","volume":"97","author":"Joo","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.ejso.2024.108258_bib21","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.21037\/tcr-20-2080","article-title":"Construction of nomograms for nasopharyngeal carcinoma containing primary tumor size and SEER stage","volume":"9","author":"Yang","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.ejso.2024.108258_bib22","doi-asserted-by":"crossref","first-page":"17027","DOI":"10.1007\/s00432-023-05399-2","article-title":"Enhancing prognostic accuracy: a SEER-based analysis for overall and cancer-specific survival prediction in cervical adenocarcinoma patients","volume":"149","author":"Chen","year":"2023","journal-title":"J\u00a0Cancer Res Clin"},{"key":"10.1016\/j.ejso.2024.108258_bib23","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.2147\/CMAR.S336892","article-title":"Nomogram predicting overall survival in patients with FIGO II to III squamous cell cervical carcinoma under radical radiotherapy: a retrospective analysis based on 2018 FIGO staging","volume":"13","author":"Zang","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ejso.2024.108258_bib24","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1007\/s00432-023-04796-x","article-title":"Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database","volume":"149","author":"Nie","year":"2023","journal-title":"J\u00a0Cancer Res Clin"},{"key":"10.1016\/j.ejso.2024.108258_bib25","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1200\/JCO.22.01424","article-title":"Racial and ethnic disparities in cervical cancer incidence, survival, and mortality by histologic subtype","volume":"41","author":"Cohen","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.21873\/anticanres.11326","article-title":"Minimally invasive lymphadenectomy in uterine cervical cancer: a systematic review","volume":"37","author":"Rizou","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2024.108258_bib27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12905-023-02726-0","article-title":"A\u00a0preoperative nomogram predicting risk of lymph node metastasis for early-stage cervical cancer","volume":"23","author":"Deng","year":"2023","journal-title":"BMC Wom Health"},{"key":"10.1016\/j.ejso.2024.108258_bib28","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/annonc\/mdp196","article-title":"Quality assurance for radical hysterectomy for cervical cancer: the view of the European organization for research and treatment of cancer--gynecological cancer group (EORTC-GCG)","volume":"20","author":"Verleye","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ygyno.2008.12.014","article-title":"Pelvic and aortic lymphadenectomy in cervical cancer: the standardization of surgical procedure and its clinical impact","volume":"113","author":"Benedetti","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib30","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/ijgc-00009577-200605000-00036","article-title":"Lymph node metastasis and lymph vascular space invasion in microinvasive squamous cell carcinoma of the uterine cervix","volume":"16","author":"Lee","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2024.108258_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/IGC.0b013e318197f3ef","article-title":"Frequency of pelvic lymph node metastases and parametrial involvement in stage IA2 cervical cancer: a population-based study and literature review","volume":"19","author":"van Meurs","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2024.108258_bib32","first-page":"377","article-title":"Tailoring pelvic lymphadenectomy for patients with stage IA2, IB1, and IIA1 uterine cervical cancer","volume":"6","author":"Zhou","year":"2015","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.ejso.2024.108258_bib33","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1007\/s10147-021-01980-2","article-title":"The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases-a literature review","volume":"26","author":"Olthof","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib34","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00404-018-4914-2","article-title":"Risk factors, microbiology and management of infected lymphocyst after lymphadenectomy for gynecologic malignancies","volume":"298","author":"Ma","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejso.2024.108258_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12905-017-0403-1","article-title":"Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study","volume":"17","author":"Kuroda","year":"2017","journal-title":"BMC Wom Health"},{"key":"10.1016\/j.ejso.2024.108258_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13019-020-01390-x","article-title":"The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis","volume":"16","author":"Kai","year":"2021","journal-title":"J\u00a0Cardiothorac Surg"},{"key":"10.1016\/j.ejso.2024.108258_bib37","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jmig.2017.02.013","article-title":"Minimally invasive surgical staging in early-stage ovarian carcinoma: a systematic review and meta-analysis","volume":"24","author":"Bogani","year":"2017","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ejso.2024.108258_bib38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygyno.2020.06.508","article-title":"Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: a multi-institutional study","volume":"159","author":"Casarin","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.radonc.2018.03.003","article-title":"The European society of gynaecological oncology\/European society for radiotherapy and oncology\/European society of pathology guidelines for the management of patients with cervical cancer","volume":"127","author":"Cibula","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib40","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","article-title":"Minimally invasive versus abdominal radical hysterectomy for cervical cancer","volume":"379","author":"Ramirez","year":"2018","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejso.2024.108258_bib41","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1804923","article-title":"Survival after minimally invasive radical hysterectomy for early-stage cervical cancer","volume":"379","author":"Melamed","year":"2018","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejso.2024.108258_bib42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ygyno.2022.07.002","article-title":"The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: survival outcomes","volume":"166","author":"Leitao","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ygyno.2023.04.030","article-title":"Ten-year outcomes following laparoscopic and open abdominal radical hysterectomy for \"low-risk\" early-stage cervical cancer: a propensity-score based analysis","volume":"174","author":"Di Donato","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ygyno.2022.07.022","article-title":"Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer","volume":"166","author":"Bogani","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2024.108258_bib45","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ijgc-2022-003735","article-title":"Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: is it time for an update?","volume":"32","author":"Rodriguez","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2024.108258_bib46","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ajog.2019.10.010","article-title":"Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone","volume":"222","author":"Matsuo","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejso.2024.108258_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11684-021-0892-z","article-title":"Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial","volume":"17","author":"Weng","year":"2023","journal-title":"Front Med-PRC"},{"key":"10.1016\/j.ejso.2024.108258_bib48","first-page":"CD5342","article-title":"Adjuvant platinum-based chemotherapy for early stage cervical cancer","volume":"11","author":"Falcetta","year":"2016","journal-title":"Cochrane DB Syst Rev"},{"key":"10.1016\/j.ejso.2024.108258_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2019-000445","article-title":"Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy","author":"van der Velden","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2024.108258_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/ijgc-2020-001974","article-title":"Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer","volume":"31","author":"Cao","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2024.108258_bib51","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ijgo.13147","article-title":"Comparison of no adjuvant treatment and radiotherapy in early-stage cervical carcinoma with intermediate risk factors","volume":"149","author":"Akilli","year":"2020","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejso.2024.108258_bib52","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ijgc-2021-002489","article-title":"Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors","volume":"31","author":"Nasioudis","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2024.108258_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2022-003918","article-title":"CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)","author":"Cibula","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2024.108258_bib54","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A\u00a0randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832400310X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832400310X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:55:43Z","timestamp":1760061343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879832400310X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S074879832400310X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108258","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of lymph node ratio in patients with non-metastatic cervical cancer treated with radical hysterectomy: A population-based study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108258"}}